Pal Czobor, PhD | Psychiatrist.com

Original Research

Executive Function Predicts Response to Antiaggression Treatment in Schizophrenia: A Randomized Controlled Trial

November 29, 2011

Menahem I. Krakowski, Pal Czobor

Original Research

Efficacy of Antipsychotic Drugs Against Hostility in the European First-Episode Schizophrenia Trial (EUFEST)

July 15, 2011

Jan Volavka, Pal Czobor, Eske M. Derks, et al

Original Research

Efficacy of Ziprasidone Against Hostility in Schizophrenia: Post Hoc Analysis of Randomized, Open-Label Study Data

April 15, 2006

Leslie Citrome, Jan Volavka, Pal Czobor, et al

Original Research

Efficacy of Aripiprazole Against Hostility in Schizophrenia and Schizoaffective Disorder: Data From 5 Double-Blind Studies

November 15, 2005

Jan Volavka, Pal Czobor, Leslie Citrome, et al

Original Research

Effects of Atypical Antipsychotics on the Syndromal Profile in Treatment-Resistant Schizophrenia

April 1, 2004

Jean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, et al

Original Research

Prolactin Levels in Schizophrenia and Schizoaffective Disorder Patients Treated With Clozapine, Olanzapine, Risperidone, or Haloperidol

January 1, 2004

Jan Volavka, Pal Czobor, Thomas B. Cooper, et al

Original Research

Olanzapine in Refractory Schizophrenia After Failure of Typical or Atypical Antipsychotic Treatment: An Open-Label Switch Study

October 1, 2002

Jean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, et al

Original Research

Clinical and Neurocognitive Effects of Clozapine and Risperidone in Treatment-Refractory Schizophrenic Patients: A Prospective Study

October 15, 1998

Jean-Pierre Lindenmayer, Adel Iskander, Mohan Park, et al